Idience Co., Ltd.
PrivateLast Round
Strategic
May 20, 2024
Total Funding Raised
$66M
Company Overview
Idience Co., Ltd. operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Strategic round in May 2024.
Idience Co., Ltd. is a biopharmaceutical company that develops targeted oncology therapies, including its lead PARP inhibitor candidate, Venadaparib.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Idience Co., Ltd. Comparables
Compare Idience Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Duke Street Bio | 87% | |
| Onconic Therapeutics | 81% | |
| Synnovation Therapeutics | 81% |
For institutional investors. Book with your work email.
Idience Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | May 20, 2024 | ||||
| Series B | Jul 1, 2022 | ||||
| Series A | Nov 9, 2020 |
For institutional investors. Book with your work email.
Idience Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Seoul Investment Partners | Series B, Series A |
| KIWOOM Securities Co., Ltd. | Series B |
| TS Investment | Series A |
| Ildong Holdings Co., Ltd. | Series B |
| Mirae Asset Capital | Series A |
| Yuanta Investment | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 28, 2024
Monthly visitors increased 84% MoM, reaching 1.8K.
- Jul 1, 2022
$12M round with participation from Ildong Holdings and KIWOOM Securities.
For institutional investors. Book with your work email.
Idience Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Idience Co., Ltd.'s valuation, stock price, and market status.
Is Idience Co., Ltd. a public or private company?
Idience Co., Ltd. is a private company.
What is the current stock price of Idience Co., Ltd.?
Idience Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Idience Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Idience Co., Ltd. worth (valuation)?
Valuation information for Idience Co., Ltd. is not publicly available.
Can I buy Idience Co., Ltd. stock?
Idience Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Idience Co., Ltd.'s last funding round?
Idience Co., Ltd.'s most recent funding round was Strategic on May 20, 2024.
Who are the main investors in Idience Co., Ltd.?
Key investors in Idience Co., Ltd. include Seoul Investment Partners, KIWOOM Securities Co., Ltd., TS Investment, Ildong Holdings Co., Ltd., Mirae Asset Capital.
Will Idience Co., Ltd. IPO soon?
No public IPO plans have been announced for Idience Co., Ltd..
How can I track Idience Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Idience Co., Ltd.'s shares on secondary markets.